Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about IPSEY Recent news which mentions IPSEY FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo June 11, 2024 Tickers GNFT IPSEF IPSEY NEWS Tags Benzinga IPSEF Media From Benzinga 3 Promising Biotech Stocks Flying Under the Radar November 08, 2023 Tickers ABOS BMRN EXEL HALO Tags IPSEY BMRN TAK From InvestorPlace Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients August 21, 2023 Tickers EXEL IPSEF IPSEY RHHBF Tags Health Care IPSEY Biotech From Benzinga Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class June 30, 2023 Tickers CBAY GNFT IPSEY Tags Expert Ideas Analyst Color GNFT From Benzinga Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients June 30, 2023 Tickers GNFT IPSEY Tags GNFT Market News Benzinga From Benzinga What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur May 22, 2023 Tickers CBAY DRRX GNFT ICPT Tags General News Briefs From Benzinga Why These Two Biotech Stocks Blasted Higher This Week January 13, 2023 Tickers ALBO AZN CINC IPSEY Tags AZN Market News Recent Press Releases From Motley Fool 2 Tiny Nasdaq Stocks Making Major Merger Moves Monday January 09, 2023 Tickers ALBO DCT IPSEY Tags DCT Recent Press Releases ^IXIC From Motley Fool France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline January 09, 2023 Tickers ALBO IPSEF IPSEY Tags ALBO IPSEY Health Care From Benzinga Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting December 09, 2022 Tickers EXEL IPSEY RHHBY TAK Tags EXEL Market News TAK From Benzinga Why Merrimack Shares Are Surging Over 200% Today? November 09, 2022 Tickers IPSEF IPSEY MACK Tags Market News Benzinga IPSEF From Benzinga Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know November 01, 2022 Tickers APLS ARDX AZN FOLD Tags News SCYX PRVB From Benzinga AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know October 02, 2022 Tickers ALNY AMLX AZN BLUE Tags ALNY THTX GSK From Benzinga Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases September 19, 2022 Tickers GNFT IPSEY Tags Eurasia Biotech Health Care From Benzinga Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure August 03, 2022 Tickers IPSEF IPSEY MACK Tags General Movers why it's moving From Benzinga This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday June 28, 2022 Tickers AFIB AGRX AGTC AMST Tags APCX Pre/Market Outlook PRQR From Benzinga Why Adaptimmune Therapeutics Stock Is Popping Today June 27, 2022 Tickers ADAP EPZM IPSEY Tags ADAP IPSEY EPZM From Motley Fool Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session June 27, 2022 Tickers AFIB AGRX AGTC ARMP Tags Trading Ideas AFIB SHCR From Benzinga Why Epizyme Stock Is Soaring Today June 27, 2022 Tickers EPZM IPSEY Tags Market News Recent Press Releases EPZM From Motley Fool The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies June 27, 2022 Tickers ALPMF ALPMY AXSM AZN Tags General M&A AXSM From Benzinga Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why June 27, 2022 Tickers EPZM IPSEF IPSEY Tags IPSEY Health Care Biotech From Benzinga Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make May 17, 2022 Tickers BMY ETSY EXEL IPSEY Tags EXEL Market News ETSY From Motley Fool The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs May 03, 2022 Tickers ACAD AQST BIIB BLTE Tags Movers OCUL News From Benzinga Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer May 03, 2022 Tickers EXEL IPSEF IPSEY Tags News Briefs Biotech From Benzinga EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer March 25, 2022 Tickers EXEL IPSEF IPSEY Tags Biotech Health Care IPSEY From Benzinga Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy March 15, 2022 Tickers BAYRY BAYZF EXEL IPSEY Tags News Briefs Hepatocellular Carcinoma From Benzinga A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge January 24, 2022 Tickers ABBV GILD HAL IBM Tags STLD IPSEY IBM From Benzinga Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease January 24, 2022 Tickers IPSEF IPSEY Tags News Briefs Biotech From Benzinga GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters December 17, 2021 Tickers BABA FUTU GNFT IPSEY Tags GNFT Market News NVAX From InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday December 17, 2021 Tickers ABEO ADGI BLIN CERN Tags ABEO OBSV JP From InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.